Microdosing glp-1 is gaining traction, but is it safe? Experts warn about compounded semaglutide, reduced efficacy, and ...

But 25-year-old Madison Burgess has thrown caution to the wind by opting to micro-dose the drug. The Michigan native revealed ...

“We would not be able to say for certain that a patient is reaping the full potential benefits of GLP-1 medications that have ...

The trial was designed to evaluate the therapy’s efficacy and safety in treating AML, as well as myelodysplastic syndromes.

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...

“Dosing the sentinel participant in our RLYB212 Phase 2 trial marks a significant milestone for our RLYB212 program and for Rallybio,” said Stephen Uden, M.D., Chief Executive Officer of Rallybio.